Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation

Oslo, Norway, 14 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic 'off the shelf' T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, invites you to a webcast presentation of its second quarter 2025 results, on Wednesday, August 20, 2025. The presentation can be followed as a live webcast accessed through a link on www.zelluna.com at 09:00 CET on Wednesday, August 20, 2025. The webcast presentation will be available on the Zelluna website, and it will be possib ...